Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ceftolozane/tazobactam regulatory update

FDA granted Fast Track designation to ceftolozane/tazobactam to treat hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP) and

Read the full 188 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE